Often it is possible to anticipate development of tumor lysis syndrome (eg, when treating cancers with rapid cell turnover) and to give large volumes of fluids and allopurinol or rasburicase before starting chemotherapy and sometimes prior to immune therapy (such as bispecific monoclonal antibodies or CAR-T-cells) to protect the kidneys from damage from uric acid.